RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Events

2020 Annual General Meeting of Shareholders

June 30, 2020
2020

The Annual General Meeting of Shareholders of QIAGEN N.V. ("AGM") will be held on Tuesday, June 30, 2020 at 03:00 p.m. (Amsterdam time) at Maaspoort, Oude Markt 30, 5911 HH Venlo, The Netherlands. .

In light of the global COVID-19 (Novel Coronavirus) outbreak, shareholders will not be given physical access to this year's Annual General Meeting and can only follow the Annual General Meeting through electronic means. With this measure, we can protect the health and safety of our shareholders and all other persons involved in our Annual General Meeting. Although it is unfortunate that we cannot hold the Annual General Meeting as usual, safety comes first for QIAGEN in this extraordinary situation.

On June 2, 2020 the total number of shares of the Company issued is 230,829,308.67 and the number of voting rights is 228,467,464. The number of voting rights does not include the treasury shares held by the Company and the fractional shares.

A webcast of the AGM will be hosted on June 30, 2020 at 3:00 p.m. CET.